Rx (Prescription Medicine)
USD $ 120.00
Cytax 300mg Injection 是一种重要的药物，用于治疗多种癌症。其活性成分，Paclitaxel，属于一类称为 taxanes 的药物。Paclitaxel 通过干扰微管的正常分解，从而影响细胞分裂。微管是细胞分裂的关键组成部分。通过破坏这一过程，Cytax 能有效抑制快速分裂癌细胞的增殖，从而减缓或停止肿瘤生长。
该注射剂主要用于治疗晚期卵巢癌、乳腺癌和非小细胞肺癌。它也可能与其他化疗药物联合使用，用于特定类型的癌症。Cytax 300mg Injection 的剂量和治疗时长取决于患者的具体情况、癌症的类型和阶段以及其对治疗的反应。该药物以静脉注射方式由合格的医疗专业人员进行给予。
Cytax 300mg Injection 常见的不良反应包括骨髓抑制（导致血细胞计数降低）、神经损伤（神经病变）、脱发、恶心、呕吐、腹泻和过敏反应。患者还可能出现疲劳、肌肉酸痛以及心律变化。如出现任何不寻常或严重的不良反应，应立即向医生报告。Cytax 300mg Injection 应储存在室温，避光保存，并放在儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Pack Quantity | |
| Strength |
其他品牌的 Paclitaxel 300 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
